These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8712723)

  • 1. Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines.
    Zhou JN; Linder S
    Anticancer Res; 1996; 16(4A):1931-5. PubMed ID: 8712723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M; Liu E; Xiong Y
    Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of p-15(INK4b) and p-16(INK4a) gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells.
    Wu WS; Hsu HY
    Biochem Biophys Res Commun; 2001 Jul; 285(2):183-7. PubMed ID: 11444823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
    Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
    EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
    Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
    Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
    Stone S; Dayananth P; Jiang P; Weaver-Feldhaus JM; Tavtigian SV; Cannon-Albright L; Kamb A
    Oncogene; 1995 Sep; 11(5):987-91. PubMed ID: 7675459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of p16 and p21(Cip1) expression in tumorigenic human bronchial epithelial cells induced by asbestos.
    Piao CQ; Zhao YL; Hei TK
    Oncogene; 2001 Nov; 20(50):7301-6. PubMed ID: 11704859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.